Fresenius Medical Care: +10%

Fresenius Medical Care: +10% 

Fresenius (Bad Homburg, Germany) has had a solid first six months of the year with its stock opening the year around $35 and eventually hitting $44 in late July. 

Perhaps the tide is turning. Its stock has been falling recently, and it closed the day on September 2 at $37.69. Recently, analyst firm Morningstar gave the firm a BB+ credit rating, stating that the firm had an above-average default risk. Morningstar gave the company a two-star rating (out of five). A dialysis device from the company is depicted above.